- Home
- CLLS vs SGC Comparison
CLLS vs SGC Comparison
Compare CLLS & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- SGC
- Stock Information
- Founded
- CLLS 1999
- SGC 1920
- Country
- CLLS France
- SGC United States
- Employees
- CLLS N/A
- SGC N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- SGC Apparel
- Sector
- CLLS Health Care
- SGC Consumer Discretionary
- Exchange
- CLLS Nasdaq
- SGC Nasdaq
- Market Cap
- CLLS 240.2M
- SGC 281.4M
- IPO Year
- CLLS 2007
- SGC N/A
- Fundamental
- Price
- CLLS $1.57
- SGC $16.42
- Analyst Decision
- CLLS Buy
- SGC Strong Buy
- Analyst Count
- CLLS 3
- SGC 2
- Target Price
- CLLS $7.00
- SGC $22.50
- AVG Volume (30 Days)
- CLLS 59.8K
- SGC 48.6K
- Earning Date
- CLLS 11-04-2024
- SGC 11-06-2024
- Dividend Yield
- CLLS N/A
- SGC 3.41%
- EPS Growth
- CLLS N/A
- SGC 79.86
- EPS
- CLLS N/A
- SGC 0.82
- Revenue
- CLLS $36,042,000.00
- SGC $567,509,000.00
- Revenue This Year
- CLLS $271.02
- SGC $5.21
- Revenue Next Year
- CLLS $33.48
- SGC $4.02
- P/E Ratio
- CLLS N/A
- SGC $20.05
- Revenue Growth
- CLLS 46.96
- SGC 4.19
- 52 Week Low
- CLLS $1.53
- SGC $11.66
- 52 Week High
- CLLS $3.55
- SGC $21.80
- Technical
- Relative Strength Index (RSI)
- CLLS 27.91
- SGC 43.16
- Support Level
- CLLS $1.85
- SGC $16.51
- Resistance Level
- CLLS $2.09
- SGC $17.40
- Average True Range (ATR)
- CLLS 0.09
- SGC 0.51
- MACD
- CLLS -0.04
- SGC -0.12
- Stochastic Oscillator
- CLLS 0.00
- SGC 0.00
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.